MIPEP Deficiency Increased LPS Resistance in Mice
Researchers discovered that removing mitochondrial intermediate peptidase in fat cells improved survival rates after exposure.
Updated on Oct. 14, 2026 in Weight Loss
A study using a mouse model found that adipocyte-specific mitochondrial intermediate peptidase (MIPEP) knockout, or aMKO, reduced mortality caused by lipopolysaccharide (LPS). This genetic modification helped the mice maintain lower levels of inflammatory cytokines after exposure.
Why it matters
Understanding how MIPEP deficiency remodels inflammatory responses in white adipose tissue provides new insight into systemic cytokine amplification. This mechanism potentially offers a pathway to mitigate severe inflammatory reactions.
The aMKO modification reduced LPS-induced inflammatory cytokine expression specifically in the liver, lungs, and spleen. This resistance to LPS-induced mortality remained consistent even when the mice experienced GDF15 deficiency.
The details
MIPEP deficiency in white adipose tissue effectively blunts systemic cytokine levels, preventing the dangerous inflammatory spikes typically associated with LPS. The experimental results show that this protection persists even when pharmacological inhibition of FGF receptors is introduced.
The Big Picture
This discovery marks a shift in our understanding of mitochondrial roles within the ongoing research into the cytokine storm mechanism in systemic inflammatory response syndrome. By identifying how MIPEP deficiency limits inflammatory output, scientists can now focus on this enzyme as a potential target for modulating immune responses.
While these results are limited to a mouse model, they provide a foundation for future therapeutic strategies aimed at controlling systemic inflammation in humans. These findings could eventually influence how clinicians approach treatment for patients prone to severe inflammatory responses.
The takeaway
These findings suggest that mitochondrial health within adipose tissue is a key factor in managing systemic inflammation. Future research will likely focus on whether targeting this specific peptidase can safely provide similar protective effects in humans.
Further reading
For more on the metabolic implications of these findings, visit the Weight Loss section.
Source note: This article includes information reported by Nature.
